NFKB1 and ependymoma: Given that the fusion protein preferentially localizes in the nucleus, persistent activation of the NF-κB pathway is thought as the primary mechanism for the RELAFUS-driven ependymoma formation as bolstered by high NF-κB activity in human and mouse RELAFUS tumors [41, 45].